世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), by Type, by Technology, and by Application - Global Forecast to 2030

Agriculture Biotechnology Market by Type of Organism (Plant, Animal, and Microbes), by Type, by Technology, and by Application - Global Forecast to 2030


<P>The agriculture biotechnology market is estimated at USD 92.19 billion in 2025 and is projected to reach USD 144.25 billion by 2030, at a CAGR of 9.4%. https://mnmimg.marketsandmarkets.com/... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
MarketsandMarkets
マーケッツアンドマーケッツ
2025年10月31日 US$4,950
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
通常2営業日以内 507 英語

英語原文をAIを使って翻訳しています。


 

Summary

<P>The agriculture biotechnology market is estimated at USD 92.19 billion in 2025 and is projected to reach USD 144.25 billion by 2030, at a CAGR of 9.4%.

https://mnmimg.marketsandmarkets.com/Images/agricultural-biotechnology-market-new-overview.webp

The growth of the agriculture biotechnology market is mainly driven by increasing global food demand, diminishing arable land, and the need for sustainable farming solutions. Biotechnology provides advanced methods to increase crop yields, improve soil health, and boost livestock productivity while reducing environmental impact. The rising use of genetically modified (GM) crops, microbial inoculants, and biofertilizers supports better resource management and less reliance on chemicals. Moreover, climate change pressures have sped up the adoption of drought-tolerant and pest-resistant crop varieties, ensuring greater resilience in farming. Governments and international groups are encouraging biotech innovations through supportive regulations, research funding, and sustainability efforts. Additionally, quick progress in genome editing, molecular diagnostics, and microbial engineering is broadening the use of agricultural biotechnology in plant, animal, and microbial systems. Collectively, these factors are driving a shift toward high-tech, eco-friendly, and high-yield agriculture worldwide.

“Plant biotechnology is projected to dominate the market during the forecast period.”
The plant biotechnology segment is expected to dominate the global agriculture biotechnology market during the forecast period. This leadership is due to widespread adoption of genetically modified (GM) crops, advancements in seed trait development, and increased use of biofertilizers and biopesticides. Rising global food demand, combined with the need for higher crop yields with limited natural resources, is fueling the adoption of plant biotechnology solutions. Farmers are increasingly opting for GM varieties that offer herbicide tolerance, pest resistance, and improved stress tolerance to achieve better yields and profits. Additionally, innovations in CRISPR and molecular breeding technologies are enhancing precision in crop improvement, enabling faster commercialization of new varieties. Supportive government policies promoting sustainable agriculture, along with public-private R&D investments, are further reinforcing this segment’s position. The growing need for climate-resilient and nutrient-rich crops will continue to make plant biotechnology a key driver of innovation in modern agriculture throughout the forecast period.

“The genetic engineering and genome editing subsegment is projected to dominate the agriculture biotechnology market during the forecast period.”
The genetic engineering and genome editing segment is expected to lead the agriculture biotechnology market during the forecast period due to its transformative effect on crop and livestock improvement. Technologies like CRISPR-Cas9, TALEN, and RNA interference (RNAi) are allowing scientists to create precise, high-yield varieties with better yield, stress tolerance, and nutritional content. An example is Calyxt’s gene-edited soybean, which produces healthier high-oleic oil and was among the first CRISPR-based crops to be commercialized in the US. Likewise, Corteva Agriscience has developed drought-tolerant maize using advanced gene-editing methods, greatly enhancing resilience in water-scarce areas.
In livestock, Genus PLC has developed pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS), a breakthrough that enhances animal welfare and cuts economic losses. Governments in Brazil, the US, and Argentina have also relaxed regulations on gene-edited crops, supporting faster commercialization. Supported by strong R&D investments, global partnerships, and evolving biosafety frameworks, genetic engineering and genome editing are set to remain the leading technologies that drive efficiency, sustainability, and innovation in agricultural biotechnology through 2030.
“Asia Pacific is projected to be the fastest-growing market during the forecast period.”
The Asia Pacific region is expected to see the fastest growth in the agriculture biotechnology market during the forecast period, fueled by increasing food demands, expanding agricultural modernization, and government-supported initiatives that promote sustainable farming practices. Countries like China, India, Japan, and the Philippines are increasingly investing in biotechnology R&D to improve crop yields, livestock health, and soil fertility. The rising adoption of genetically modified (GM) crops, microbial biofertilizers, and bio-based pest control products is transforming the region’s agricultural landscape.
India’s approval of GM mustard (Dhara Mustard Hybrid-11) in 2023 and China’s increasing commercialization of gene-edited soybean and maize varieties highlight the region’s progressive regulatory approach. Additionally, strong support from regional organizations and public-private partnerships is driving innovation in genome editing, fermentation technologies, and microbial applications. With rapid population growth, limited arable land, and growing focus on food security, the Asia Pacific region is expected to remain the most dynamic and opportunity-rich area in the agriculture biotechnology market through 2030.
In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations in the agriculture biotechnology market.
? By Company Type: Tier 1?25%, Tier 2?45%, and Tier 3?30%
? By Designation: CXOs?20%, Managers?50%, Executives?30%
? By Region: North America?25%, Europe?20%, Asia Pacific?30%, South America?15%, and Rest of the World?10%
Prominent companies in the market include Bayer Crop Science, Corteva Agriscience, BASF SE, Syngenta AG, Zoetis Inc., Elanco Animal Health, and Novonesis (Novozymes and Chr. Hansen)
Research Coverage
This research report categorizes the agriculture biotechnology market by organism type (plants, animals, microbes), type (genetic modification, crop protection, soil enhancement, stress tolerance, transgenic animals, vaccines, feed additives, diagnostics, biofertilizers, biocontrol agents, microbial enzymes & biostimulants, microbial genomics & fermentation), technology (genetic engineering, molecular diagnostics, tissue culture, CRISPR, fermentation, metagenomics, synthetic biology, and molecular marker-assisted selection), application (crop protection, yield enhancement, disease resistance, animal health management, soil health improvement, and sustainable nutrient cycling), end user (farmers and producer groups, agribusinesses, seed and input companies, research institutions, and government agencies), and region (North America, Europe, Asia Pacific, South America, the Middle East, and Africa).
The report’s scope includes detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of agricultural biotechnology. A comprehensive analysis of key industry players offers insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers and acquisitions, and recent developments in the agriculture biotechnology market. This report also features a competitive analysis of emerging startups within the agriculture biotechnology ecosystem. Additionally, the study covers industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes, among other topics.
Reasons to Buy This Report
The report will provide market leaders and new entrants with approximate revenue figures for the overall agriculture biotechnology sector and its subsegments. It will also help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse and offers information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following points.
? Analysis of key drivers (growing demand for sustainable and high-yield biotechnology-based agriculture), restraints (high regulatory hurdles and lengthy approval processes for GMOs), opportunities (increasing adoption of microbial and bio-based agricultural inputs globally), and challenges (public skepticism and ethical concerns over genetic modification technologies) influencing the growth of the agriculture biotechnology market
? Product Development/Innovation: Detailed insights into ongoing R&D initiatives in genome editing, CRISPR applications, microbial biofertilizers, and biocontrol agents are included, along with emerging product launches across plant, animal, and microbial biotechnology segments.
? Market Development: The report offers comprehensive information about expanding market opportunities across developed and emerging regions, emphasizing growing investment in biotechnology-enabled agriculture.
? Market Diversification: Includes detailed analysis of new product innovations, regional adoption patterns, government-funded biotechnology initiatives, and expansion of key players into new applications such as climate-resilient crops and animal health solutions.
? Competitive Assessment: In-depth assessment of market share, company strategies, product portfolios, and innovation footprints of leading players such as Bayer AG (Germany), Corteva Agriscience (US), BASF SE (Germany), Syngenta AG (Switzerland), Novonesis (Denmark), Ginkgo Bioworks (US), Zoetis Inc. (US), and ADM Animal Nutrition (US), among others in the agriculture biotechnology ecosystem.

ページTOPに戻る


Table of Contents

<P>1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 46
1.3 STUDY SCOPE 47
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 47
1.3.2 INCLUSIONS AND EXCLUSIONS 48
1.3.3 YEARS CONSIDERED 49
1.4 UNITS CONSIDERED 49
1.4.1 CURRENCY CONSIDERED 49
1.5 STAKEHOLDERS 50
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
2.1.1 SECONDARY DATA 53
2.1.1.1 Key data from secondary sources 53
2.1.2 PRIMARY DATA 53
2.1.2.1 Key data from primary sources 54
2.1.2.2 Key primary participants 54
2.1.2.2.1 AGRICULTURE BIOTECHNOLOGY COMPANIES 54
2.1.2.3 Breakdown of primary interviews 55
2.1.2.4 Key industry insights 55
2.2 MARKET SIZE ESTIMATION 56
2.2.1 BOTTOM-UP APPROACH 57
2.2.2 TOP-DOWN APPROACH 58
2.3 DATA TRIANGULATION 61
2.4 FACTOR ANALYSIS 62
2.5 RESEARCH ASSUMPTIONS 63
2.6 RESEARCH LIMITATIONS 64
3 EXECUTIVE SUMMARY 65
4 PREMIUM INSIGHTS 71
4.1 AGRICULTURE BIOTECHNOLOGY MARKET OVERVIEW 71
4.2 AGRICULTURE BIOTECHNOLOGY MARKET: GROWTH RATES OF MAJOR REGIONAL SUBMARKETS 72
4.3 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET FOR PLANT BIOTECHNOLOGY,
BY TYPE AND COUNTRY 73
4.4 AGRICULTURE BIOTECHNOLOGY MARKET, BY ORGANISM TYPE AND REGION 74
4.5 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY 75
4.6 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION 75
4.7 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION 76
5 MARKET OVERVIEW 77
5.1 INTRODUCTION 77
5.2 MARKET DYNAMICS 77
5.2.1 DRIVERS 78
5.2.1.1 Growing Need for Sustainable Food Production 78
5.2.1.2 Government Support and Regulatory Approvals 79
5.2.1.3 Rising Focus on Reducing Chemical Inputs 79
5.2.2 RESTRAINTS 79
5.2.2.1 Public Perception and Ethical Concerns 79
5.2.2.2 Infrastructure and Cold Chain Limitations 80
5.2.3 OPPORTUNITIES 80
5.2.3.1 Expansion in Emerging Economies 80
5.2.3.2 Focus on Carbon-negative and Regenerative Agriculture 81
5.2.3.3 Growth in Microbial and Bio-based Inputs 81
5.2.4 CHALLENGES 82
5.2.4.1 Regulatory Uncertainty and Trade Barriers 82
5.2.4.2 Dominance of Few Multinational Players 82
5.2.4.3 Climate and Disease Variability 82
5.3 IMPACT OF GEN AI ON AGRICULTURE BIOTECHNOLOGY 83
5.3.1 INTRODUCTION 83
5.3.2 USE OF GEN AI IN AGRICULTURE BIOTECHNOLOGY 84
5.3.3 CASE STUDY ANALYSIS 85
5.3.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via
Synthetic Imagery 85
5.3.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation 85
5.3.4 IMPACT ON AGRICULTURE BIOTECHNOLOGY MARKET 86
5.3.5 ADJACENT ECOSYSTEM WORKING ON GEN AI 86
6 INDUSTRY TRENDS 87
6.1 INTRODUCTION 87
6.2 PORTER’S FIVE FORCES ANALYSIS 87
6.2.1 INTENSITY OF COMPETITIVE RIVALRY 88
6.2.2 BARGAINING POWER OF SUPPLIERS 88
6.2.3 BARGAINING POWER OF BUYERS 89
6.2.4 THREAT OF SUBSTITUTES 89
6.2.5 THREAT OF NEW ENTRANTS 89
?
6.3 MACROECONOMIC INDICATORS 89
6.3.1 GLOBAL POPULATION GROWTH & FOOD DEMAND 89
6.3.2 STABLE GLOBAL GDP GROWTH AND MACRO PROJECTIONS 90
6.4 SUPPLY CHAIN ANALYSIS 91
6.5 VALUE CHAIN ANALYSIS 92
6.6 ECOSYSTEM ANALYSIS 93
6.6.1 DEMAND SIDE 94
6.6.2 SUPPLY SIDE 94
6.7 INDICATIVE PRICING ANALYSIS 94
6.7.1 INDICATIVE PRICING ANALYSIS, BY KEY COMPANY AND ORGANISM 95
6.7.2 INDICATIVE PRICING BY REGION 97
6.8 TRADE ANALYSIS 99
6.8.1 TRADE ANALYSIS OF HS CODE 843280: PREPARED CULTURE MEDIA FOR DEVELOPMENT OR MAINTENANCE OF MICROORGANISMS, INCLUDING VIRUSES AND THE LIKE, OR OF PLANT, HUMAN, OR ANIMAL CELLS 99
6.8.1.1 Export Trends of Agriculture Biotechnology under HS Code
382100 (2020?2024) 99
6.8.1.2 Import Trends of Agriculture Biotechnology under HS Code
382100 (2020?2024) 100
6.9 KEY CONFERENCES & EVENTS 103
6.10 TRENDS IMPACTING CUSTOMERS’ BUSINESSES 104
6.11 INVESTMENT AND FUNDING SCENARIO 105
6.12 CASE STUDY ANALYSIS 106
6.12.1 PIVOT BIO’S GENE-EDITED NITROGEN-FIXING MICROBES (2025) 106
6.12.2 NOVONESIS MICROBIAL SEED INOCULANT (JUMPSTART?) (2024) 106
6.12.3 RECOMBINETICS ? GENE-EDITED LIVESTOCK FOR DISEASE RESISTANCE AND WELFARE ENHANCEMENT (2024) 107
6.13 IMPACT OF 2025 US TARIFF - AGRICULTURE BIOTECHNOLOGY MARKET 107
6.13.1 INTRODUCTION 107
6.13.2 KEY TARIFF RATES 108
6.13.3 PRICE IMPACT ANALYSIS 108
6.13.4 IMPACT ON COUNTRY/REGION 110
6.13.4.1 United States 110
6.13.4.2 European Union 110
6.13.4.3 China 110
6.13.5 IMPACT ON END-USE INDUSTRIES 110
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 111
7.1 INTRODUCTION 111
7.2 DECISION-MAKING PROCESS 111
7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 112
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 112
7.3.2 BUYING CRITERIA 113
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 114
7.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 114
7.6 MARKET PROFITABILITY 115
8 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 116
8.1 INTRODUCTION 116
8.2 KEY EMERGING TECHNOLOGIES 116
8.3 COMPLEMENTARY TECHNOLOGIES 117
8.4 TECHNOLOGY/PRODUCT ROADMAP 118
8.5 PATENT ANALYSIS 118
8.5.1 LIST OF MAJOR PATENTS 120
8.6 FUTURE APPLICATIONS 124
8.7 IMPACT OF AI/GEN AI ON AGRICULTURE BIOTECHNOLOGY MARKET 124
8.7.1 TOP USE CASES AND MARKET POTENTIAL 125
8.7.1.1 AI Use Cases in Agriculture Biotechnology Market 125
8.7.1.1.1 AI-driven Genomic Selection and Trait Discovery 125
8.7.1.1.2 Precision Bio-input Design and Microbial Optimization 125
8.7.1.1.3 Market Potential Impact of AI in Agricultural Biotechnology 125
8.7.1.1.4 Acceleration of R&D and Commercialization Pipelines 125
8.7.1.1.5 Enabling Data-driven Sustainable Agriculture and Global Scalability 126
8.7.2 BEST PRACTICES IN AGRICULTURE BIOTECHNOLOGY PROCESSING 126
8.7.3 CASE STUDIES OF AI IMPLEMENTATION IN AGRICULTURE BIOTECHNOLOGY MARKET 127
8.7.3.1 Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery 127
8.7.3.2 PhytoSynth: Generative AI for Crop Disease Data Generation 128
8.7.4 INTERCONNECTED & ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 128
8.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN AGRICULTURE BIOTECHNOLOGY MARKET 128
8.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 129
9 SUSTAINABILITY AND REGULATORY LANDSCAPE 130
9.1 INTRODUCTION 130
9.2 REGIONAL REGULATIONS AND COMPLIANCE 130
9.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 130
9.2.2 INDUSTRY STANDARDS 133
9.3 SUSTAINABILITY INITIATIVES 134
9.3.1 CARBON IMPACT AND ECO-APPLICATIONS OF AGRICULTURE BIOTECHNOLOGY 134
?
9.4 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 134
9.5 CERTIFICATIONS, LABELING, ECO-STANDARDS 135
10 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM 137
10.1 INTRODUCTION 138
10.2 PLANTS 139
10.2.1 GROWING GLOBAL FOOD DEMAND, CLIMATE CHANGE RESILIENCE, AND SUSTAINABILITY GOALS ACCELERATING ADOPTION OF PLANT BIOTECHNOLOGY 139
10.3 ANIMALS 140
10.3.1 RISING PROTEIN DEMAND, DISEASE PREVENTION NEEDS, AND SUSTAINABLE LIVESTOCK PRODUCTION DRIVING ANIMAL BIOTECHNOLOGY ADVANCEMENTS 140
10.4 MICROBIALS 141
10.4.1 RISING DEMAND FOR SUSTAINABLE SOIL HEALTH, BIOFERTILIZERS, AND ECO-FRIENDLY PEST CONTROL DRIVES MICROBIAL BIOTECHNOLOGY GROWTH 141
11 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE 143
11.1 INTRODUCTION 144
11.2 PLANT BIOTECHNOLOGY MARKET, BY TYPE 144
11.2.1 GROWING FOCUS ON ENHANCING CROP YIELD, STRESS RESISTANCE, AND SUSTAINABILITY 144
11.2.2 GENETIC MODIFICATION 149
11.2.2.1 Crop protection (Biopesticides, Herbicide-tolerant Traits) 149
11.2.2.1.1 Rising pest resistance, yield loss, and sustainability goals drive innovation in biotechnology-based crop protection 149
11.2.2.2 Soil enhancement (Biofertilizers, Microbial Solutions) 150
11.2.2.2.1 Declining soil fertility and sustainable farming practices are driving demand for biotechnology-based soil enhancement solutions 150
11.2.2.3 Stress tolerance (Drought/Heat-resistant Crops) 150
11.2.2.3.1 Climate change, erratic weather, and yield instability are driving demand for stress-tolerant biotechnology crops 150
11.2.2.4 Animal biotechnology market, by type 150
11.2.2.4.1 Focus on improving livestock productivity, health, and genetic performance 150
11.2.3 TRANSGENIC ANIMALS 152
11.2.3.1 Animal vaccine development 152
11.2.3.1.1 Increasing livestock diseases and zoonotic threats drive demand for advanced biotechnology-based animal vaccine solutions 152
11.2.3.2 Feed additives & nutrient optimization 153
11.2.3.2.1 Rising demand for efficient, sustainable livestock production drives adoption of biotechnology-based feed additives globally 153
?
11.2.3.3 Animal health diagnostics 153
11.2.3.3.1 Growing disease incidence and need for early detection drive innovation in biotechnology-based animal diagnostics 153
11.2.3.4 Microbial biotechnology market, by type 153
11.2.3.4.1 Expanding use of microbes in agriculture enhances yield and sustainability 153
11.2.4 MICROBIAL BIOFERTILIZERS 155
11.2.4.1 Biocontrol agents (Fungi, Bacteria) 156
11.2.4.1.1 Stringent pesticide regulations and growing demand for residue-free, sustainable crop protection accelerate biocontrol adoption globally 156
11.2.4.2 Microbial enzymes & biostimulants 157
11.2.4.2.1 Rising demand for eco-friendly, stress-resilient crop enhancement solutions drives microbial enzyme and biostimulant adoption globally 157
11.2.4.3 Microbial genomics & fermentation 158
11.2.4.3.1 Advancements in microbial genomics and precision fermentation enable high-efficiency, scalable bio-based agricultural innovations globally 158
12 AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION 159
12.1 INTRODUCTION 160
12.2 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION 160
12.2.1 CROP PROTECTION 161
12.2.1.1 Increasing pest resistance and need for sustainable pest control drive innovation in biotech crop protection 161
12.2.2 YIELD ENHANCEMENT 162
12.2.2.1 Rising food demand and limited arable land accelerate adoption of high-yield biotechnology-based crop systems 162
12.2.3 NUTRITIONAL QUALITY IMPROVEMENT 162
12.2.3.1 Rising focus on combating micronutrient deficiency fuels demand for biotechnology-based nutritional crop improvement 162
12.2.4 CLIMATE-RESILIENT CROPS 162
12.2.4.1 Intensifying climate variability and food security concerns drive investment in biotechnology-based resilient crop development 162
12.3 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION 163
12.3.1 DISEASE RESISTANCE 164
12.3.1.1 Rising livestock disease outbreaks and antibiotic resistance drive adoption of genetic and molecular resistance solutions 164
12.3.2 GROWTH & PRODUCTIVITY ENHANCEMENT 164
12.3.2.1 Increasing protein demand and emission-reduction mandates promote biotechnology adoption for livestock growth and productivity enhancement 164
12.3.3 ANIMAL WELFARE SOLUTIONS 165
12.3.3.1 Rising ethical concerns and regulatory focus on humane production drive demand for biotechnology-enabled animal welfare systems 165
?
12.3.4 VETERINARY THERAPEUTICS 165
12.3.4.1 Growing prevalence of zoonotic diseases and advancements in biologics fuel growth of veterinary biotechnology therapeutics 165
12.4 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION 165
12.4.1 SOIL HEALTH MANAGEMENT 167
12.4.1.1 Increasing focus on regenerative agriculture and soil restoration drives adoption of microbial soil health management technologies 167
12.4.2 PEST & DISEASE CONTROL 167
12.4.2.1 Rising pesticide restrictions and demand for organic produce drive adoption of microbial pest control solutions 167
12.4.3 SUSTAINABLE NUTRIENT CYCLING 167
12.4.3.1 Growing nutrient inefficiency and fertilizer price volatility accelerate adoption of microbial nutrient cycling technologies 167
12.4.4 BIOREMEDIATION & WASTE UTILIZATION 168
12.4.4.1 Rising agricultural waste generation and environmental pollution drive adoption of microbial bioremediation technologies 168
13 AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY 169
13.1 INTRODUCTION 170
13.2 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY 170
13.2.1 TISSUE CULTURE 171
13.2.1.1 Growing need for disease-free, high-quality planting materials and export-grade crops accelerates tissue culture adoption globally 171
13.2.2 SOMATIC HYBRIDIZATION 172
13.2.2.1 Advancements in cell fusion and interspecies hybridization foster innovation in developing resilient and high-yield crop hybrids 172
13.2.3 MOLECULAR DIAGNOSTICS 172
13.2.3.1 Increasing global biosecurity regulations and focus on disease-free seed trade enhance molecular diagnostic adoption in agriculture 172
13.2.4 GENETIC ENGINEERING 172
13.2.4.1 Genetic engineering represents most transformative technology in modern plant biotechnology 172
13.3 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY 173
13.3.1 EMBRYO RESCUE & TRANSFER 174
13.3.1.1 Growing demand for genetic improvement, reproductive efficiency, and conservation drives widespread adoption of embryo transfer technologies 174
13.3.2 GENETIC ENGINEERING & CRISPR 175
13.3.2.1 Expanding use of CRISPR-Cas9 in livestock breeding drives precision genetic improvement and sustainability in animal farming 175
13.3.3 MOLECULAR DIAGNOSTICS 175
13.3.3.1 Rising livestock disease incidence and demand for rapid, accurate pathogen detection bolster molecular diagnostic adoption globally 175
13.3.4 VACCINE BIOTECHNOLOGIES 175
13.3.4.1 Rising zoonotic disease threats and focus on antibiotic-free livestock production accelerate biotech vaccine innovations globally 175
13.4 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY 176
13.4.1 FERMENTATION TECHNOLOGY 177
13.4.1.1 Increasing use of sustainable biofertilizers and precision fermentation drives growth in microbial input production technologies 177
13.4.2 METAGENOMICS & MICROBIAL GENOMICS 178
13.4.2.1 Expanding soil microbiome research and AI-based genomic analysis accelerate innovation in precision microbial biotechnology 178
13.4.3 MOLECULAR MARKER-ASSISTED SELECTION 178
13.4.3.1 Rising need for efficient microbial strain identification promotes adoption of molecular marker-assisted selection technologies 178
13.4.4 SYNTHETIC BIOLOGY 178
13.4.4.1 Expanding investments in engineered microbes and metabolic design accelerate adoption of synthetic biology in agriculture and biotechnology 178
14 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION 180
14.1 INTRODUCTION 181
14.2 NORTH AMERICA 184
14.2.1 US 195
14.2.1.1 Expanding bioengineering investments, AI-integrated field trials, and streamlined GMO regulations drive US biotechnology market leadership 195
14.2.2 CANADA 200
14.2.2.1 Supportive biosafety regulations and strong genomic research collaborations boost biotechnology advancement and sustainability in Canada 200
14.2.3 MEXICO 204
14.2.3.1 Expanding gene-editing research and sustainable agriculture policies accelerate biotechnology adoption and innovation in Mexico 204
14.3 EUROPE 208
14.3.1 GERMANY 219
14.3.1.1 Strong federal R&D support and industrial-scale bio-innovation reinforce Germany’s leadership in sustainable agricultural biotechnology 219
14.3.2 ITALY 223
14.3.2.1 Expanding bioinput research programs and regional sustainability initiatives accelerate biotechnology adoption in Italy’s agri-sector 223
14.3.3 FRANCE 227
14.3.3.1 Strong government R&D investment and progressive biosafety policies enhance France’s leadership in sustainable agricultural biotechnology 227
14.3.4 SPAIN 232
14.3.4.1 Expanding gene-editing research and strong government funding boost Spain’s sustainable agricultural biotechnology development 232
14.3.5 UK 236
14.3.5.1 Regulatory reforms and strong R&D investments strengthen UK’s leadership in precision agricultural biotechnology innovation 236
14.3.6 REST OF EUROPE 240
14.4 ASIA PACIFIC 245
14.4.1 CHINA 255
14.4.1.1 Expanding GMO approvals and strong state-led R&D investments reinforce China’s leadership in agricultural biotechnology innovation 255
14.4.2 INDIA 260
14.4.2.1 Government-led biotech missions and microbial innovation drive India’s agricultural transformation toward sustainable productivity growth 260
14.4.3 JAPAN 264
14.4.3.1 Strong government funding and innovation-driven industry partnerships accelerate Japan’s agricultural biotechnology advancement 264
14.4.4 AUSTRALIA & NEW ZEALAND 268
14.4.4.1 Progressive gene-editing reforms and climate-resilient R&D accelerate biotechnology growth in Australia and New Zealand 268
14.4.5 REST OF ASIA PACIFIC 273
14.5 SOUTH AMERICA 277
14.5.1 BRAZIL 287
14.5.1.1 Expanding GMO approvals and microbial innovation solidify Brazil’s leadership in agricultural biotechnology development 287
14.5.2 ARGENTINA 292
14.5.2.1 Global leadership in GM wheat and microbial bioinputs strengthens Argentina’s agricultural biotechnology innovation capacity 292
14.5.3 REST OF SOUTH AMERICA 296
14.6 REST OF THE WORLD 300
14.6.1 MIDDLE EAST 310
14.6.1.1 Government-backed innovation and food security strategies drive biotechnology adoption across Middle East’s arid regions 310
14.6.2 AFRICA 315
14.6.2.1 Expanding GM approvals and microbial innovation strengthen Africa’s resilience in sustainable agricultural biotechnology adoption 315
15 COMPETITIVE LANDSCAPE 320
15.1 OVERVIEW 320
15.2 KEY PLAYERS’ STRATEGIES, 2022?2024 320
15.3 REVENUE ANALYSIS, 2022?2024 328
15.4 MARKET SHARE ANALYSIS, 2024 331
15.5 BRAND/PRODUCT COMPARISON 335
15.5.1 BAYER AG (GERMANY) 335
15.5.2 SYNGENTA AG (SWITZERLAND) 336
15.5.3 CORTEVA (US) 336
15.5.4 ZOETIS INC. (US) 336
15.5.5 NOVONESIS GROUP (DENMARK) 336
?
15.6 COMPANY VALUATION AND FINANCIAL METRICS 337
15.6.1 COMPANY VALUATION 337
15.6.2 EV/EBITDA 337
15.7 PLANT BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 338
15.7.1 STARS 338
15.7.2 EMERGING LEADERS 338
15.7.3 PERVASIVE PLAYERS 338
15.7.4 PARTICIPANTS 339
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 340
15.7.5.1 Company footprint 340
15.7.5.2 Region footprint 340
15.7.5.3 Type footprint 341
15.7.5.4 Application footprint 341
15.8 ANIMAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 342
15.8.1 STARS 342
15.8.2 EMERGING LEADERS 342
15.8.3 PERVASIVE PLAYERS 342
15.8.4 PARTICIPANTS 343
15.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 344
15.8.5.1 Company footprint 344
15.8.5.2 Region footprint 344
15.8.5.3 Type footprint 345
15.8.5.4 Application footprint 345
15.9 MICROBIAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 346
15.9.1 STARS 346
15.9.2 EMERGING LEADERS 346
15.9.3 PERVASIVE PLAYERS 346
15.9.4 PARTICIPANTS 347
15.9.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 348
15.9.5.1 Company footprint 348
15.9.5.2 Region footprint 348
15.9.5.3 Type footprint 349
15.9.5.4 Application footprint 349
15.10 COMPETITIVE SCENARIO 350
15.10.1 PRODUCT LAUNCHES 350
15.10.2 DEALS 352
15.10.3 EXPANSIONS 353
?
16 COMPANY PROFILES 356
16.1 PLANT BIOTECHNOLOGY COMPANIES 356
16.1.1 BASF SE 356
16.1.1.1 Business overview 356
16.1.1.2 Products/Solutions/Services offered 358
16.1.1.3 Recent developments 359
16.1.1.3.1 Product launches 359
16.1.1.3.2 Deals 360
16.1.1.3.3 Expansions 360
16.1.1.4 MnM view 361
16.1.1.4.1 Key strengths 361
16.1.1.4.2 Strategic choices 361
16.1.1.4.3 Weaknesses and competitive threats 361
16.1.2 BAYER AG 362
16.1.2.1 Business overview 362
16.1.2.2 Products/Solutions/Services offered 363
16.1.2.3 Recent developments 364
16.1.2.3.1 Product launches 364
16.1.2.3.2 Deals 365
16.1.2.3.3 Expansions 367
16.1.2.4 MnM view 367
16.1.2.4.1 Key strengths 367
16.1.2.4.2 Strategic choices 367
16.1.2.4.3 Weaknesses and competitive threats 368
16.1.3 CORTEVA AGRISCIENCE 369
16.1.3.1 Business overview 369
16.1.3.2 Products/Solutions/Services offered 370
16.1.3.3 Recent developments 372
16.1.3.3.1 Product launches 372
16.1.3.3.2 Deals 373
16.1.3.4 MnM view 375
16.1.3.4.1 Key strengths 375
16.1.3.4.2 Strategic choices 375
16.1.3.4.3 Weaknesses and competitive threats 376
16.1.4 SYNGENTA 377
16.1.4.1 Business overview 377
16.1.4.2 Products/Solutions/Services offered 378
16.1.4.3 Recent developments 381
16.1.4.3.1 Product launches 381
16.1.4.3.2 Deals 382
16.1.4.3.3 Expansions 386
?
16.1.4.4 MnM view 387
16.1.4.4.1 Key strengths 387
16.1.4.4.2 Strategic choices 387
16.1.4.4.3 Weaknesses and competitive threats 387
16.1.5 KWS SAAT SE & CO. KGAA 388
16.1.5.1 Business overview 388
16.1.5.2 Products/Solutions/Services offered 389
16.1.5.3 Recent developments 391
16.1.5.3.1 Product launches 391
16.1.5.3.2 Deals 391
16.1.5.3.3 Other developments 392
16.1.5.4 MnM view 392
16.1.5.4.1 Key strengths 392
16.1.5.4.2 Strategic choices 392
16.1.5.4.3 Weaknesses and competitive threats 393
16.1.6 UPL 394
16.1.6.1 Business overview 394
16.1.6.2 Products/Solutions/Services offered 395
16.1.6.3 Recent developments 397
16.1.6.3.1 Product launches 397
16.1.6.3.2 Deals 399
16.1.6.4 MnM view 400
16.1.6.4.1 Key strengths 400
16.1.6.4.2 Strategic choices 401
16.1.6.4.3 Weaknesses and competitive threats 401
16.1.7 FMC CORPORATION 402
16.1.7.1 Business overview 402
16.1.7.2 Products/Solutions/Services offered 403
16.1.7.3 Recent developments 404
16.1.7.3.1 Product launches 404
16.1.7.3.2 Deals 405
16.1.7.3.3 Expansions 407
16.1.7.3.4 Other developments 407
16.1.7.4 MnM view 408
16.1.8 SUMITOMO CHEMICAL CO., LTD. 409
16.1.8.1 Business overview 409
16.1.8.2 Products/Solutions/Services offered 410
16.1.8.3 Recent developments 410
16.1.8.3.1 Deals 410
16.1.8.3.2 Expansions 411
16.1.8.4 MnM view 412
?
16.1.9 NUFARM 413
16.1.9.1 Business overview 413
16.1.9.2 Products/Solutions/Services offered 414
16.1.9.3 Recent developments 415
16.1.9.3.1 Product launches 415
16.1.9.3.2 Deals 415
16.1.9.4 MnM view 416
16.1.10 PRO FARM GROUP 417
16.1.10.1 Business overview 417
16.1.10.2 Products/Solutions/Services offered 418
16.1.10.3 Recent developments 419
16.1.10.3.1 Product launches 419
16.1.10.4 MnM view 419
16.2 ANIMAL BIOTECHNOLOGY COMPANIES 420
16.2.1 ZOETIS SERVICES LLC 420
16.2.1.1 Business overview 420
16.2.1.2 Products/Solutions/Services offered 421
16.2.1.3 Recent developments 422
16.2.1.3.1 Other developments 422
16.2.1.3.2 Expansions 422
16.2.1.4 MnM view 423
16.2.1.4.1 Key strengths 423
16.2.1.4.2 Strategic choices 423
16.2.1.4.3 Weaknesses and competitive threats 423
16.2.2 ELANCO OR ITS AFFILIATES 424
16.2.2.1 Business overview 424
16.2.2.2 Products/Solutions/Services offered 425
16.2.2.3 Recent developments 426
16.2.2.3.1 Product launches 426
16.2.2.4 MnM view 426
16.2.2.4.1 Key strengths 426
16.2.2.4.2 Strategic choices 427
16.2.2.4.3 Weaknesses and competitive threats 427
16.2.3 MERCK & CO., INC. 428
16.2.3.1 Business overview 428
16.2.3.2 Products/Solutions/Services offered 429
16.2.3.3 Recent developments 430
16.2.3.3.1 Expansions 430
16.2.3.4 MnM view 430
16.2.3.4.1 Key strengths 430
16.2.3.4.2 Strategic choices 430
16.2.3.4.3 Weaknesses and competitive threats 431
16.2.4 CEVA 432
16.2.4.1 Business overview 432
16.2.4.2 Products/Solutions/Services offered 432
16.2.4.3 Recent developments 433
16.2.4.3.1 Expansions 433
16.2.4.4 MnM view 434
16.2.5 VIRBAC 435
16.2.5.1 Business overview 435
16.2.5.2 Products/Solutions/Services offered 436
16.2.5.3 Recent developments 437
16.2.5.3.1 Product launches 437
16.2.5.4 MnM view 437
16.2.5.4.1 Key strengths 437
16.2.5.4.2 Strategic choices 437
16.2.5.4.3 Weaknesses and competitive threats 438
16.2.6 HESTER BIOSCIENCES LIMITED 439
16.2.6.1 Business overview 439
16.2.6.2 Products/Solutions/Services offered 440
16.2.6.3 MnM view 441
16.2.7 GENUS PLC 442
16.2.7.1 Business overview 442
16.2.7.2 Products/Solutions/Services offered 443
16.2.7.3 MnM view 444
16.2.8 VAXXINOVA 445
16.2.8.1 Business overview 445
16.2.8.2 Products/Solutions/Services offered 445
16.2.8.3 MnM view 446
16.2.9 AB VISTA 447
16.2.9.1 Business overview 447
16.2.9.2 Products/Solutions/Services offered 447
16.2.9.3 MnM view 448
16.2.10 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 449
16.2.10.1 Business overview 449
16.2.10.2 Products/Solutions/Services offered 450
16.2.10.3 Recent developments 451
16.2.10.3.1 Product launches 451
16.2.10.4 MnM view 452
16.2.10.4.1 Key strengths 452
16.2.10.4.2 Strategic choices 452
16.2.10.4.3 Weaknesses and competitive threats 452
?
16.3 MICROBE BIOTECHNOLOGY COMPANIES 453
16.3.1 VALENT U.S.A. LLC 453
16.3.1.1 Business overview 453
16.3.1.2 Products/Solutions/Services offered 454
16.3.1.3 Recent developments 455
16.3.1.3.1 Deals 455
16.3.1.3.2 Expansions 455
16.3.1.4 MnM view 455
16.3.1.4.1 Key strengths 455
16.3.1.4.2 Strategic choices 456
16.3.1.4.3 Weaknesses and competitive threats 456
16.3.2 NOVONESIS GROUP 457
16.3.2.1 Business overview 457
16.3.2.2 Products/Solutions/Services offered 458
16.3.2.3 Recent developments 459
16.3.2.3.1 Product launches 459
16.3.2.3.2 Deals 459
16.3.2.3.3 Expansions 460
16.3.2.4 MnM view 460
16.3.2.4.1 Key strengths 460
16.3.2.4.2 Strategic choices 460
16.3.2.4.3 Weaknesses and competitive threats 461
16.3.3 INDIGO AG, INC. 462
16.3.3.1 Business overview 462
16.3.3.2 Products/Solutions/Services offered 463
16.3.3.3 Recent developments 464
16.3.3.3.1 Product launches 464
16.3.3.3.2 Deals 464
16.3.3.3.3 Expansions 465
16.3.3.4 MnM view 465
16.3.3.4.1 Key strengths 465
16.3.3.4.2 Strategic choices 465
16.3.3.4.3 Weaknesses and competitive threats 465
16.3.4 PIVOT BIO 466
16.3.4.1 Business overview 466
16.3.4.2 Products/Solutions/Services offered 467
16.3.4.3 Recent developments 467
16.3.4.3.1 Other developments 467
16.3.4.3.2 Expansions 468
16.3.4.4 MnM view 468
16.3.4.4.1 Key strengths 468
16.3.4.4.2 Strategic choices 469
16.3.4.4.3 Weaknesses and competitive threats 469
16.3.5 BIOATLANTIS LTD. 470
16.3.5.1 Business overview 470
16.3.5.2 Products/Solutions/Services offered 471
16.3.5.3 Recent developments 471
16.3.5.3.1 Product launches 471
16.3.5.3.2 Deals 472
16.3.5.4 MnM view 472
16.3.5.4.1 Key strengths 472
16.3.5.4.2 Strategic choices 473
16.3.5.4.3 Weaknesses and competitive threats 473
16.3.6 CERTIS USA L.L.C. 474
16.3.6.1 Business overview 474
16.3.6.2 Products/Solutions/Services offered 475
16.3.6.3 Recent developments 477
16.3.6.3.1 Product launches 477
16.3.6.3.2 Deals 477
16.3.6.4 MnM view 477
16.3.7 ZYMOLENT BIOSCIENCES PVT. LTD. 478
16.3.7.1 Business overview 478
16.3.7.2 Products/Solutions/Services offered 479
16.3.7.3 Recent developments 479
16.3.7.3.1 Other developments 479
16.3.7.4 MnM view 479
16.3.8 AGRICEN 480
16.3.8.1 Business overview 480
16.3.8.2 Products/Solutions/Services offered 481
16.3.8.3 Recent developments 481
16.3.8.3.1 Deals 481
16.3.8.4 MnM view 482
16.3.9 VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD. 483
16.3.9.1 Business overview 483
16.3.9.2 Products/Solutions/Services offered 484
16.3.9.3 Recent developments 486
16.3.9.4 MnM view 486
16.3.10 GROUNDWORK BIOAG 487
16.3.10.1 Business overview 487
16.3.10.2 Products/Solutions/Services offered 488
16.3.10.3 Recent developments 489
16.3.10.3.1 Product launches 489
16.3.10.3.2 Deals 489
16.3.10.4 MnM view 490
17 ADJACENT AND RELATED MARKETS 491
17.1 INTRODUCTION 491
17.2 LIMITATIONS 491
17.3 PLANT BIOTECHNOLOGY MARKET 491
17.3.1 MARKET DEFINITION 491
17.3.2 MARKET OVERVIEW 492
17.4 AGRICULTURAL MICROBIALS MARKET 493
17.4.1 MARKET DEFINITION 493
17.4.2 AGRICULTURAL MICROBIALS MARKET, BY APPLICATION 493
18 APPENDIX 495
18.1 DISCUSSION GUIDE 495
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 503
18.3 CUSTOMIZATION OPTIONS 505
18.4 RELATED REPORTS 506
18.5 AUTHOR DETAILS 506

ページTOPに戻る



List of Tables/Graphs

<P>TABLE 1 USD EXCHANGE RATES, 2020?2024 50
TABLE 2 AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT, 2025 VS. 2030 65
TABLE 3 AGRICULTURE BIOTECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 87
TABLE 4 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR PLANT BIOTECHNOLOGY 95
TABLE 5 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR MICROBIAL BIOTECHNOLOGY 96
TABLE 6 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR ANIMAL BIOTECHNOLOGY 96
TABLE 7 PLANT BIOTECHNOLOGY ? INDICATIVE REGIONAL PRICING, 2024 97
TABLE 8 MICROBIAL BIOTECHNOLOGY ? INDICATIVE REGIONAL PRICING, 2024 98
TABLE 9 ANIMAL BIOTECHNOLOGY ? INDICATIVE REGIONAL PRICING, 2024 98
TABLE 10 TOP 10 EXPORTERS OF HS CODE 382100, 2020?2024 (USD THOUSAND) 101
TABLE 11 TOP 10 IMPORTERS OF HS CODE 382100, 2020?2024 (USD THOUSAND) 102
TABLE 12 TOP 10 EXPORTERS OF HS CODE 382100, 2020?2024 (TONS) 102
TABLE 13 TOP 10 IMPORTERS OF HS CODE 382100, 2020?2024 (TONS) 103
TABLE 14 AGRICULTURE BIOTECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025?2026 103
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 108
TABLE 16 EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT 109
TABLE 17 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES 110
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE 113
TABLE 19 KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE 114
TABLE 20 LIST OF MAJOR PATENTS FOR AGRICULTURE BIOTECHNOLOGY MARKET,
2021?2024 120
TABLE 21 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 130
TABLE 22 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 131
TABLE 23 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 131
TABLE 24 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 132
TABLE 25 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 132
TABLE 26 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM,
2020?2024 (USD MILLION) 138
TABLE 27 AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM,
2025?2030 (USD MILLION) 139
TABLE 28 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,
2020?2024 (USD MILLION) 139
TABLE 29 PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,
2025?2030 (USD MILLION) 140
TABLE 30 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,
2020?2024 (USD MILLION) 141
TABLE 31 ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,
2025?2030 (USD MILLION) 141
TABLE 32 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,
2020?2024 (USD MILLION) 142
TABLE 33 MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,
2025?2030 (USD MILLION) 142
TABLE 34 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 145
TABLE 35 PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 145
TABLE 36 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,
BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 146
TABLE 37 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,
BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 146
TABLE 38 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,
BY REGION, 2020-2024 (THOUSAND METRIC TONS) 146
TABLE 39 CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,
BY REGION, 2025-2030 (THOUSAND METRIC TONS) 147
TABLE 40 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION,
2020-2024 (THOUSAND METRIC TONS) 147
TABLE 41 BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION,
2025-2030 (THOUSAND METRIC TONS) 147
TABLE 42 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION,
2020-2024 (THOUSAND METRIC TONS) 148
TABLE 43 BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION,
2025-2030 (THOUSAND METRIC TONS) 148
TABLE 44 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 148
TABLE 45 PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 149
TABLE 46 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 151
TABLE 47 ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 152
TABLE 48 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 154
TABLE 49 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 154
TABLE 50 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024
(THOUSAND METRIC TONS) 155
TABLE 51 MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030
(THOUSAND METRIC TONS) 155
TABLE 52 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS) 156
TABLE 53 MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS) 156
TABLE 54 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET,
BY REGION, 2020-2024 (THOUSAND METRIC TONS) 157
TABLE 55 MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET,
BY REGION, 2025-2030 (THOUSAND METRIC TONS) 157
TABLE 56 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020?2024 (USD MILLION) 161
TABLE 57 PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025?2030 (USD MILLION) 161
TABLE 58 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020?2024 (USD MILLION) 163
TABLE 59 ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025?2030 (USD MILLION) 164
TABLE 60 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 166
TABLE 61 MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 166
TABLE 62 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020?2024 (USD MILLION) 171
TABLE 63 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025?2030 (USD MILLION) 171
TABLE 64 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020?2024 (USD MILLION) 174
TABLE 65 ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025?2030 (USD MILLION) 174
TABLE 66 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 177
TABLE 67 MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 177
TABLE 68 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020?2024 (USD MILLION) 182
TABLE 69 AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025?2030 (USD MILLION) 182
TABLE 70 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020?2024 (USD MILLION) 182
TABLE 71 PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025?2030 (USD MILLION) 183
TABLE 72 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2020?2024 (USD MILLION) 183
TABLE 73 ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2025?2030 (USD MILLION) 183
TABLE 74 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2020?2024 (USD MILLION) 184
TABLE 75 MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2025?2030 (USD MILLION) 184
TABLE 76 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 185
TABLE 77 NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 186
TABLE 78 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 186
TABLE 79 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 186
TABLE 80 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 187
TABLE 81 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 187
TABLE 82 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 187
TABLE 83 NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 188
TABLE 84 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 188
TABLE 85 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 188
TABLE 86 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 189
TABLE 87 NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 189
TABLE 88 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 189
TABLE 89 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 190
TABLE 90 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 190
TABLE 91 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 190
TABLE 92 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 191
TABLE 93 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 191
TABLE 94 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 191
TABLE 95 NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 192
TABLE 96 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 192
TABLE 97 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 192
TABLE 98 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 193
TABLE 99 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 193
TABLE 100 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020-2024 (THOUSAND METRIC TONS) 193
TABLE 101 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025-2030 (THOUSAND METRIC TONS) 194
TABLE 102 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 194
TABLE 103 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 194
TABLE 104 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 195
TABLE 105 NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 195
TABLE 106 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 196
TABLE 107 US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 196
TABLE 108 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 196
TABLE 109 US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 197
TABLE 110 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 197
TABLE 111 US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 197
TABLE 112 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 198
TABLE 113 US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 198
TABLE 114 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 198
TABLE 115 US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 199
TABLE 116 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 199
TABLE 117 US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 199
TABLE 118 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 200
TABLE 119 CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 200
TABLE 120 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 201
TABLE 121 CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 201
TABLE 122 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 201
TABLE 123 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 202
TABLE 124 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 202
TABLE 125 CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 202
TABLE 126 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 203
TABLE 127 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 203
TABLE 128 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 203
TABLE 129 CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 204
TABLE 130 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 204
TABLE 131 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 205
TABLE 132 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 205
TABLE 133 MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 205
TABLE 134 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 206
TABLE 135 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 206
TABLE 136 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 206
TABLE 137 MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 207
TABLE 138 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 207
TABLE 139 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 207
TABLE 140 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 208
TABLE 141 MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 208
TABLE 142 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 209
TABLE 143 EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 209
TABLE 144 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 209
TABLE 145 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 210
TABLE 146 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 210
TABLE 147 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 210
TABLE 148 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 211
TABLE 149 EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 211
TABLE 150 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 211
TABLE 151 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 212
TABLE 152 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 212
TABLE 153 EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 212
TABLE 154 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 213
TABLE 155 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 213
TABLE 156 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 213
TABLE 157 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 214
TABLE 158 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 214
TABLE 159 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 214
TABLE 160 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 215
TABLE 161 EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 215
TABLE 162 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 215
TABLE 163 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 216
TABLE 164 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 216
TABLE 165 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 216
TABLE 166 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020-2024 (THOUSAND METRIC TONS) 217
TABLE 167 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025-2030 (THOUSAND METRIC TONS) 217
TABLE 168 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 217
TABLE 169 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 218
TABLE 170 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 218
TABLE 171 EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 218
TABLE 172 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 219
TABLE 173 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 219
TABLE 174 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 220
TABLE 175 GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 220
TABLE 176 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 220
TABLE 177 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 221
TABLE 178 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 221
TABLE 179 GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 221
TABLE 180 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 222
TABLE 181 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 222
TABLE 182 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 222
TABLE 183 GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 223
TABLE 184 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 223
TABLE 185 ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 224
TABLE 186 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 224
TABLE 187 ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 224
TABLE 188 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 225
TABLE 189 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 225
TABLE 190 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 225
TABLE 191 ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 226
TABLE 192 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 226
TABLE 193 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 226
TABLE 194 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 227
TABLE 195 ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 227
TABLE 196 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 228
TABLE 197 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 228
TABLE 198 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 228
TABLE 199 FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 229
TABLE 200 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 229
TABLE 201 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 229
TABLE 202 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 230
TABLE 203 FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 230
TABLE 204 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 230
TABLE 205 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 231
TABLE 206 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 231
TABLE 207 FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 231
TABLE 208 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 232
TABLE 209 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 232
TABLE 210 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 233
TABLE 211 SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 233
TABLE 212 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 233
TABLE 213 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 234
TABLE 214 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 234
TABLE 215 SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 234
TABLE 216 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 235
TABLE 217 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 235
TABLE 218 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 235
TABLE 219 SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 236
TABLE 220 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 236
TABLE 221 UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 237
TABLE 222 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 237
TABLE 223 UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 237
TABLE 224 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 238
TABLE 225 UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 238
TABLE 226 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 238
TABLE 227 UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 239
TABLE 228 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 239
TABLE 229 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 239
TABLE 230 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 240
TABLE 231 UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 240
TABLE 232 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 241
TABLE 233 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 241
TABLE 234 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 241
TABLE 235 REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 242
TABLE 236 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 242
TABLE 237 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 242
TABLE 238 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 243
TABLE 239 REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 243
TABLE 240 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 243
TABLE 241 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 244
TABLE 242 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 244
TABLE 243 REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 244
TABLE 244 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 246
TABLE 245 ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 246
TABLE 246 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 246
TABLE 247 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 247
TABLE 248 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 247
TABLE 249 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 247
TABLE 250 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 248
TABLE 251 ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 248
TABLE 252 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 248
TABLE 253 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 249
TABLE 254 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 249
TABLE 255 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 249
TABLE 256 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 250
TABLE 257 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 250
TABLE 258 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 250
TABLE 259 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 251
TABLE 260 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 251
TABLE 261 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 251
TABLE 262 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 252
TABLE 263 ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 252
TABLE 264 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 252
TABLE 265 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 253
TABLE 266 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 253
TABLE 267 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 253
TABLE 268 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020-2024 (THOUSAND METRIC TONS) 254
TABLE 269 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025-2030 (THOUSAND METRIC TONS) 254
TABLE 270 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 254
TABLE 271 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 254
TABLE 272 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 255
TABLE 273 ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 255
TABLE 274 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 256
TABLE 275 CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 256
TABLE 276 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 256
TABLE 277 CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 257
TABLE 278 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 257
TABLE 279 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 257
TABLE 280 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 258
TABLE 281 CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 258
TABLE 282 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 258
TABLE 283 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 259
TABLE 284 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 259
TABLE 285 CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 259
TABLE 286 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 260
TABLE 287 INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 260
TABLE 288 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 261
TABLE 289 INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 261
TABLE 290 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 261
TABLE 291 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 262
TABLE 292 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 262
TABLE 293 INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 262
TABLE 294 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 263
TABLE 295 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 263
TABLE 296 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 263
TABLE 297 INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 264
TABLE 298 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 264
TABLE 299 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 265
TABLE 300 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 265
TABLE 301 JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 265
TABLE 302 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020?2024 (USD MILLION) 266
TABLE 303 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025?2030 (USD MILLION) 266
TABLE 304 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 266
TABLE 305 JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 267
TABLE 306 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 267
TABLE 307 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 267
TABLE 308 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 268
TABLE 309 JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 268TABLE 310 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 269
TABLE 311 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 269
TABLE 312 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020?2024 (USD MILLION) 269
TABLE 313 AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025?2030 (USD MILLION) 270
TABLE 314 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 270
TABLE 315 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 270
TABLE 316 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020?2024 (USD MILLION) 271
TABLE 317 AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025?2030 (USD MILLION) 271
TABLE 318 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,
BY TYPE, 2020?2024 (USD MILLION) 271
TABLE 319 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,
BY TYPE, 2025?2030 (USD MILLION) 272
TABLE 320 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,
BY APPLICATION, 2020?2024 (USD MILLION) 272
TABLE 321 AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,
BY APPLICATION, 2025?2030 (USD MILLION) 272
TABLE 322 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 273
TABLE 323 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 273
TABLE 324 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 274
TABLE 325 REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 274
TABLE 326 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 274
TABLE 327 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 275
TABLE 328 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020?2024 (USD MILLION) 275
TABLE 329 REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025?2030 (USD MILLION) 275
TABLE 330 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 276
TABLE 331 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 276
TABLE 332 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020?2024 (USD MILLION) 276
TABLE 333 REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025?2030 (USD MILLION) 277
TABLE 334 SOUTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 277
TABLE 335 SOUTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 278
TABLE 336 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 278
TABLE 337 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 278
TABLE 338 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 279
TABLE 339 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 279
TABLE 340 SOUTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS) 279
TABLE 341 SOUTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS) 280
TABLE 342 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 280
TABLE 343 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 280
TABLE 344 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 281
TABLE 345 SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 281
TABLE 346 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MILLION) 281
TABLE 347 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2025?2030 (USD MILLION) 282
TABLE 348 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2020?2024 (USD MILLION) 282
TABLE 349 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,
2025?2030 (USD MILLION) 282
TABLE 350 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2020?2024 (USD MILLION) 283
TABLE 351 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,
2025?2030 (USD MILLION) 283
TABLE 352 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2020?2024 (USD MILLION) 283
TABLE 353 SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,
2025?2030 (USD MILLION) 284
TABLE 354 SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,
2020?2024 (USD MIL

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(農業・林業)の最新刊レポート

MarketsandMarkets社の Agriculture Industry分野 での最新刊レポート

本レポートと同じKEY WORD(agriculture)の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/12/02 10:26

156.70 円

182.16 円

209.66 円

ページTOPに戻る